Effects of activated vitamin D, alfacalcidol, and low-intensity aerobic exercise on osteopenia and muscle atrophy in type 2 diabetes mellitus model rats

被引:22
作者
Akagawa, Manabu [1 ]
Miyakoshi, Naohisa [1 ]
Kasukawa, Yuji [1 ]
Ono, Yuichi [1 ]
Yuasa, Yusuke [1 ]
Nagahata, Itsuki [1 ]
Sato, Chiaki [1 ]
Tsuchie, Hiroyuki [1 ]
Nagasawa, Hiroyuki [1 ]
Hongo, Michio [1 ]
Shimada, Yoichi [1 ]
机构
[1] Akita Univ, Grad Sch Med, Dept Orthoped Surg, Akita, Akita, Japan
基金
日本学术振兴会;
关键词
BONE-MINERAL DENSITY; SKELETAL-MUSCLE; INSULIN-RESISTANCE; D SUPPLEMENTATION; OSTEOPOROTIC FRACTURE; BODY-COMPOSITION; GLYCEMIC CONTROL; HIP FRACTURE; OLDER-ADULTS; RISK;
D O I
10.1371/journal.pone.0204857
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Diabetes mellitus causes secondary osteoporosis and muscle atrophy. The ability of alfacalcidol (ALF) and exercise (Exe) to inhibit osteoporosis and muscle atrophy in type 2 diabetes mellitus (T2DM) model rats was examined. Twenty-week-old Otsuka Long-Evans Tokushima Fatty rats were randomized to ALF (orally 0.1 mu g/kg/day), Exe (treadmill exercise at 10 m/min, 60 min/day, 5 days/week), Comb (ALF and Exe), and Cont (T2DM control treated with vehicle and no exercise) groups (n = 8-10 per group). Sedentary Long-Evans Tokushima Otsuka rats were used as a non-hyperphagic control. After treatment for 2 or 6 weeks, blood glucose (BG) levels, cross-sectional area (CSA) of tibialis anterior muscle fibers, femoral bone mineral density (BMD), and relative quantities of muscle anabolic markers (Pax7, MyoD, and myogenin) and catabolic markers (Atrogin-1, MuRF1, and REDD1) of the soleus muscle assessed by real-time polymerase chain reaction assays were measured. Exe and Comb treatments for 6 weeks decreased BG levels compared with those of the Cont group. ALF, Exe, and Comb treatments for 2 and 6 weeks recovered the CSA compared with that of the Cont group. ALF and Comb treatments for 6 weeks increased femoral BMDs compared with those of the Cont group. After 2 weeks of treatment, Comb treatment increased MyoD expression and decreased MuRF1 expression. ALF or Exe monotherapy significantly decreased Atrogin-1 or MuRF1 expression after 2 weeks of treatment, respectively. After 6 weeks of treatment, ALF and Comb treatments decreased Atrogin-1 and REDD1. These results demonstrate that a combination of ALF and Exe improved CSA from the early phase of treatment by stimulating skeletal muscle differentiation and suppressing muscle catabolic genes. Improvements in BG, BMD, and CSA were observed as long-term effects of the combination therapy. Continued suppression of muscle catabolic genes was observed as a background to these effects.
引用
收藏
页数:15
相关论文
共 60 条
[21]   Update of mortality attributable to diabetes for the IDF Diabetes Atlas: Estimates for the year 2013 [J].
IDF Diabetes Atlas Group .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2015, 109 (03) :461-465
[22]   RETRACTED: Effect of treadmill exercise on bone mass in female rats (Retracted article. See vol. 71, pg. 414, 2022) [J].
Iwamoto, J ;
Takeda, T ;
Sato, Y .
EXPERIMENTAL ANIMALS, 2005, 54 (01) :1-6
[23]   Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture [J].
Janghorbani, Mohsen ;
Van Dam, Rob M. ;
Willett, Walter C. ;
Hu, Frank B. .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2007, 166 (05) :495-505
[24]   Effects of alfacalcidol on muscle strength, muscle fatigue, and bone mineral density in normal and ovariectomized rats [J].
Kasukawa, Yuji ;
Miyakoshi, Naohisa ;
Maekawa, Shigeto ;
Nozaka, Koji ;
Noguchi, Hideaki ;
Shimada, Yoichi .
BIOMEDICAL RESEARCH-TOKYO, 2010, 31 (05) :273-279
[25]   SPONTANEOUS LONG-TERM HYPERGLYCEMIC RAT WITH DIABETIC COMPLICATIONS - OTSUKA LONG-EVANS TOKUSHIMA FATTY (OLETF) STRAIN [J].
KAWANO, K ;
HIRASHIMA, T ;
MORI, S ;
SAITOH, Y ;
KUROSUMI, M ;
NATORI, T .
DIABETES, 1992, 41 (11) :1422-1428
[26]   Interactions Between Muscle Tissues and Bone Metabolism [J].
Kawao, Naoyuki ;
Kaji, Hiroshi .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2015, 116 (05) :687-695
[27]   Effects of aerobic exercise on lipids and lipoproteins in adults with type 2 diabetes: A meta-analysis of randomized-controlled trials [J].
Kelley, G. A. ;
Kelley, K. S. .
PUBLIC HEALTH, 2007, 121 (09) :643-655
[28]   Prevalence and Determinant Factors of Sarcopenia in Patients With Type 2 Diabetes The Korean Sarcopenic Obesity Study (KSOS) [J].
Kim, Tae Nyun ;
Park, Man Sik ;
Yang, Sae Jeong ;
Yoo, Hye Jin ;
Kang, Hyun Joo ;
Song, Wook ;
Seo, Ji A. ;
Kim, Sin Gon ;
Kim, Nan Hee ;
Baik, Sei Hyun ;
Choi, Dong Seop ;
Choi, Kyung Mook .
DIABETES CARE, 2010, 33 (07) :1497-1499
[29]   Effects of eldecalcitol on bone and skeletal muscles in glucocorticoid-treated rats [J].
Kinoshita, Hayato ;
Miyakoshi, Naohisa ;
Kasukawa, Yuji ;
Sakai, Sadaoki ;
Shiraishi, Ayako ;
Segawa, Toyohito ;
Ohuchi, Kentaro ;
Fujii, Masashi ;
Sato, Chie ;
Shimada, Yoichi .
JOURNAL OF BONE AND MINERAL METABOLISM, 2016, 34 (02) :171-178
[30]   Patients With Type 2 Diabetes Show a Greater Decline in Muscle Mass, Muscle Strength, and Functional Capacity With Aging [J].
Leenders, Marika ;
Verdijk, Lex B. ;
van der Hoeven, Letty ;
Adam, Jos J. ;
van Kranenburg, Janneau ;
Nilwik, Rachel ;
van Loon, Luc J. C. .
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2013, 14 (08) :585-592